ATOS Earnings

Quarterly EPS
$-0.90
Q3 2024
$-0.75
Q4 2024
$-0.78
Q1 2025
$-0.98
Q2 2025
$-1.05
Q3 2025
$-1.27
Q4 2025
$-1.11
Q1 2026
$-0.95
Q2 2026
Latest RevenueN/A
Latest Net Income-8491000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.950-8491000+3.1%
Q1 2026-$1.110-9589000-42.3%
Q4 2025-$1.270-10937000-69.3%
Q3 2025-$1.050-8692000-16.7%
Q2 2025-$0.980-8423000-30.7%
Q1 2025-$0.780-6718000-4.0%
Q4 2024-$0.750-6347000+19.4%
Q3 2024-$0.900-7230000-20.0%
Q2 2024-$0.750-6049000
Q1 2024-$0.750-5878000
Q4 2023-$0.930-7754000
Q3 2023-$0.750-6229000
Atossa Therapeutics (ATOS) — Earnings